Your browser doesn't support javascript.
loading
Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison services.
Maas, Lieke; Boonen, Annelies; Li, Nannan; Wyers, Caroline E; Van den Bergh, Joop P; Hiligsmann, Mickaël.
Afiliación
  • Maas L; Department of Health Services research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
  • Boonen A; Department of Health Services research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
  • Li N; Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Wyers CE; Department of Health Services research, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, The Netherlands.
  • Van den Bergh JP; Department of Internal Medicine, VieCuri Medical Center, Venlo, The Netherlands.
  • Hiligsmann M; Department of Internal Medicine, NUTRIM, Maastricht University Medical Center, Maastricht, The Netherlands.
Article en En | MEDLINE | ID: mdl-38860294
ABSTRACT

BACKGROUND:

This study aims to assess the lifetime cost-effectiveness of a multi-component adherence intervention (MCAI), including a patient decision aid and motivational interviewing, compared to usual care in patients with a recent fracture attending fracture liaison services (FLS) and eligible for anti-osteoporosis medication (AOM). RESEARCH DESIGN AND

METHODS:

Data on AOM initiation and one-year persistence were collected from a quasi-experimental study conducted between 2019 and 2023 in two Dutch FLS centers. An individual level, state-transition Markov model was used to simulate lifetime costs and quality-adjusted life years (QALYs) with a societal perspective of MCAI vs usual care. One-way and probabilistic sensitivity analyses were conducted including variation in additional FLS and MCAI costs (no MCAI cost in baseline).

RESULTS:

MCAI was associated with gain in QALYs (0.0012) and reduction in costs (-€16) and is therefore dominant. At the Dutch willingness-to-pay threshold of €50,000/QALY, MCAI remained cost-effective when increasing costs of the FLS visit or the yearly maintenance cost for MCAI up to +€60. Probabilistic sensitivity analysis demonstrated MCAI to be dominant in 54% of the simulations and cost-effective in 87% with a threshold of €50,000/QALY.

CONCLUSIONS:

A MCAI implemented in FLS centers may lead to cost-effective allocation of resources in FLS care, depending on extra costs.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Asunto de la revista: FARMACOLOGIA Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Asunto de la revista: FARMACOLOGIA Año: 2024 Tipo del documento: Article